Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer A Chan

Showing results (111-120 of 182) with videos related to

Pageof 19
Sort By:
Genome Biology|October 10, 2024
Spatiotemporal modeling reveals high-resolution invasion states in glioblastomaVarsha Thoppey Manoharan, Aly Abdelkareem, Gurveer Gill, et al.
Journal of the National Cancer Institute|August 19, 2011
Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803Kimmie Ng, Shuji Ogino, Jeffrey A Meyerhardt, et al.
Journal of the National Cancer Institute|November 30, 2014
Aspirin and COX-2 inhibitor use in patients with stage III colon cancerKimmie Ng, Jeffrey A Meyerhardt, Andrew T Chan, et al.
Investigational New Drugs|January 4, 2020
A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancerLipika Goyal, Surendra Pal Chaudhary, Eunice L Kwak, et al.
Communications Biology|July 14, 2022
Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progressionJamie Zagozewski, Stephanie Borlase, Brent J Guppy, et al.
British Journal of Cancer|May 19, 2023
Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomasNitya Raj, Jennifer A Chan, Stephanie J Wang, et al.
Pancreas|April 18, 2013
Consensus guidelines for the management and treatment of neuroendocrine tumorsPamela L Kunz, Diane Reidy-Lagunes, Lowell B Anthony, et al.
The Oncologist|April 13, 2013
Multicenter phase II study of tivozanib (AV-951) and everolimus (RAD001) for patients with refractory, metastatic colorectal cancerBrian M Wolpin, Kimmie Ng, Andrew X Zhu, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Spatial epigenomic niches underlie glioblastoma cell state plasticitySam Kint, Subhi Talal Younes, Shuozhen Bao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2025
Phase II trial of cabozantinib in combination with nivolumab for advanced extrapancreatic neuroendocrine tumors (epNET)Kimberly J Perez, Nora Horick, Joanna Baginska, et al.
Pageof 19

Showing results (111-120 of 182) with videos related to

Sort By:
Pageof 19
Genome Biology|October 10, 2024
Spatiotemporal modeling reveals high-resolution invasion states in glioblastomaVarsha Thoppey Manoharan, Aly Abdelkareem, Gurveer Gill, et al.
Journal of the National Cancer Institute|August 19, 2011
Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803Kimmie Ng, Shuji Ogino, Jeffrey A Meyerhardt, et al.
Journal of the National Cancer Institute|November 30, 2014
Aspirin and COX-2 inhibitor use in patients with stage III colon cancerKimmie Ng, Jeffrey A Meyerhardt, Andrew T Chan, et al.
Investigational New Drugs|January 4, 2020
A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancerLipika Goyal, Surendra Pal Chaudhary, Eunice L Kwak, et al.
Communications Biology|July 14, 2022
Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progressionJamie Zagozewski, Stephanie Borlase, Brent J Guppy, et al.
British Journal of Cancer|May 19, 2023
Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomasNitya Raj, Jennifer A Chan, Stephanie J Wang, et al.
Pancreas|April 18, 2013
Consensus guidelines for the management and treatment of neuroendocrine tumorsPamela L Kunz, Diane Reidy-Lagunes, Lowell B Anthony, et al.
The Oncologist|April 13, 2013
Multicenter phase II study of tivozanib (AV-951) and everolimus (RAD001) for patients with refractory, metastatic colorectal cancerBrian M Wolpin, Kimmie Ng, Andrew X Zhu, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Spatial epigenomic niches underlie glioblastoma cell state plasticitySam Kint, Subhi Talal Younes, Shuozhen Bao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2025
Phase II trial of cabozantinib in combination with nivolumab for advanced extrapancreatic neuroendocrine tumors (epNET)Kimberly J Perez, Nora Horick, Joanna Baginska, et al.
Pageof 19